- AU$18.80m
- AU$27.01m
- AU$20.53m
IDT Australia soars on upgraded annual earnings forecasts
IDT Australia climbs on positive FY26 outlook
Brief: Idt Australia Forecasts FY26 EBITDA Loss Of A$1.5m-A$2m
IDT Australia eyes strongest session in over four years as EBITDA loss narrows
Brief: IDT Australia Posts FY Revenues Of A$19.9 Million
Brief: IDT Australia Announces Planned Retirement Of CFO Mahendran Vasanthakumar
IDT Australia falls most in over three years after wider FY loss forecast
Brief: Idt Australia Reports CEO Resignation & Trading Update
Brief: IDT Australia Seeks Trading Halt
IDT Australia rises on MoU with US-based drug-delivery platform
Brief: IDT Australia Says Co Signs Agreement For Manufacturing Facility
Brief: Idt Australia Posts Quarterly Revenue A$4.1 Million
Brief: IDT Australia Secures Manufacturing Contract With Nacuity Pharmaceuticals For RP Treatment
IDT Australia gains on $1.9 million contract
Brief: Idt Australia On Track To Deliver Material Uplift In Its FY Result Compared To FY24
Brief: IDT Australia Sees HY Revenue To Jump 82%
IDT Australia rises to 2-1/2-month high on upbeat HY revenue growth outlook
Brief: IDT Australia Ltd Says Secures New Loan Facility With Scotpac
Brief: Idt Australia Annoucnes Termination Of Discussions With Mynd